A special terpene combination (Rowatinex®) improves stone clearance after extracorporeal shockwave lithotripsy in urolithiasis patients: Results of a placebo-controlled randomised controlled trial

Urologia Internationalis

Volumn 86, Issue 1, 2011, Pages 102-109

  Romics, Imre ^a   Siller, György ^b   Kohnen, Ralf ^e   Mavrogenis, Stelios ^a   Varga, József ^c   Holman, Endre ^d  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Karolyi Hospital   (Hungary)

^c Uzsoki Utcai Hospital   (Hungary)

^d Kiskunhalasi Semmelweis Kórház ^*  (Hungary)

^e RPS   (United Kingdom)

Author keywords

Extracorporeal shockwave lithotripsy; Kidney stones; Rowatinex ; Terpenes; Urolithiasis

Indexed keywords

ANALGESIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; PLACEBO; ROWATINEX; SPASMOLYTIC AGENT; TERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ECHOGRAPHY; EXTRACORPOREAL LITHOTRIPSY; FEMALE; FEVER; FOLLOW UP; HEADACHE; HEMATURIA; HUMAN; INTRAVENOUS PYELOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NEPHROLITHIASIS; PAIN ASSESSMENT; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL; RASH; RENOGRAPHY; STONE FORMATION; TREATMENT DURATION; URETER STONE; URINARY TRACT OBSTRUCTION; VERTIGO; VISUAL ANALOG SCALE; VOMITING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LITHOTRIPSY; MALE; MIDDLE AGED; TERPENES; TREATMENT OUTCOME; UROLITHIASIS;

EID: 79951811300     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320999     Document Type: Article

References (29)

1. Healy KA, Ogan K: Nonsurgical management of urolithiasis: an overview of expulsive therapy. J Endourol 2005; 19: 759-767. (Pubitemid 41434435)
2. Park S: Medical management of urinary stone disease. Expert Opin Pharmacother 2007; 8: 1117-1125. (Pubitemid 46929304)
3. Pietrow PK, Karellas ME: Medical management of common urinary calculi. Am Fam Physician 2006; 74: 86-94. (Pubitemid 44049737)
4. Dawson C, Whitfield HN: The long-term results of treatment of urinary stones. Br J Urol 1994; 74: 397-404. (Pubitemid 24318210)
5. Ko°ar A, Sarica K, Aydos K, Küpeli S, Türkölmez K, Göǧüs O: Comparative study of longterm stone recurrence after extracorporeal shock wave lithotripsy and open stone surgery for kidney stones. Int J Urol 1999; 6: 125-129. (Pubitemid 30406826)
6. Madaan S, Joyce AD: Limitations of extracorporeal shock wave lithotripsy. Curr Opin Urol 2007; 17: 109-113. (Pubitemid 46220278)
7. Galvin DJ, Pearle MS: The contemporary management of renal and ureteric calculi. BJU Int 2006; 98: 1283-1288. (Pubitemid 44721244)
8. Tan YH, Wong M: How significant are clinically insignificant residual fragments following lithotripsy? Curr Opin Urol 2005; 15: 127-131. (Pubitemid 40388270)
9. Geinitz W: Animal experiments on urinary calculus prevention (in German). Munch Med Wochenschr 1956; 98: 895-897.
10. Hasegawa M, Toda T, Hara N, Doi S: Effect of the terpene combination in experimental calcium oxalate nephrolithiasis (in Japanese). Nishi Nihon Hinyo 1982; 44: 213-220. (Pubitemid 12068167)
11. Hasegawa M, Toda, T, Kitada H, Kakigi K, Doi S, Hara N, Tanaka S: Effect of the terpene drug Rowatin on experimental urolithiasis. Basic Pharmacol Ther 1979; 7: 3865-3875.
12. European Association of Urology: Guidelines on urolithiasis. Arnhem, European Association of Urology, 2001.
13. El-Nahas AR, El-Assmy AM, Madbouly K, Sheir KZ: Predictors of clinical significance of residual fragments after extracorporeal shockwave lithotripsy for renal stones. J Endourol 2006; 20: 870-874. (Pubitemid 44907014)
14. Kim FJ, Rice KR: Prediction of shockwave failure in patients with urinary tract stones. Curr Opin Urol 2006; 16: 88-92. (Pubitemid 43964567)
15. Khaitan A, Gupta NP, Hemal AK, Dogra PN, Seth A, Aron M: Post-ESWL, clinically insignificant residual stones: reality or myth? Urology 2002;59:20-24. (Pubitemid 34059299)
16. Siller G, Kottász S, Pálfi Z: Rowatinex kapszula hatékonyságának vizsgálata ESWLkezelés után keletkezett kõfragmentumokra. Magyar Urol 1998; 10: 139-146. (Pubitemid 28330947)
17. Engelstein D, Kahan E, Servadio C: Rowatinex for the treatment of ureterolithiasis. J Urol (Paris) 1992; 98: 98-100.
18. Mukamel E, Engelstein D, Simon D, Servadio C: The value of Rowatinex in the treatment of ureterolithiasis. J Urol (Paris) 1987; 93: 31-33. (Pubitemid 17042514)
19. Asai J, Tsay Y-C, Miyake K, Makino M: Treatment of urolithiasis with terpene preparation, Rowatinex. Nagoya, Nagoya University, 1959.
20. Dufour A, André P: A report on the experiments carried out with Rowatinex. Paris, Hospital of Paris, 1961.
21. Caramia G, di Gregorio L, Tarantino ML, Galuffo A, Iacolino R, Caramia M: Uric acid, phosphate and oxalate stones: treatment and prophylaxis. Urol Int 2004; 72(suppl 1):24-28. (Pubitemid 38608358)
22. Tanaka S, Handa T, Fukuhara M, Hara N, Doi S, Goto M: Effects of some of the terpene combinations on the activity product of calcium oxalate urolithiasis in rats (in Japanese). Iyakuhin Kenkyu 1982; 13: 340.
23. Cipriani P, Mancini C: Microbiological activity of a terpene product used in the treatment of urinary diseases (in Italian; offprint). Gazz Int Med Chir 1972, vol 77.
24. Huntington Research Center: Report on the bactericidal activity of Rowatinex. 1961.
25. Kikuth W: Bacteriological study of the basic substances of Rowachol and Rowatinex. Internal report, 1955.
26. Horvath N: The use and effect of the terpene combination in nephrolithiasis. Arztl Prax 1963; 15: 917-918.
27. Santos FA, Rao VS: Antiinflammatory and antinociceptive effects of 1,8-cineole a terpenoid oxide present in many plant essential oils. Phytother Res 2000; 14: 240-244. (Pubitemid 30410050)
28. Santos FA, Silva RM, Campos AR, de Araujo RP, Lima Junior RC, Rao VS: 1,8-cineole (eucalyptol), a monoterpene oxide attenuates the colonic damage in rats on acute TNBS-colitis. Food Chem Toxicol 2004; 42: 579-584. (Pubitemid 38314828)
29. Seitz Ch, Liatsikos E, Porpiglia F, Tiselius HG, Zwergel U: Medical therapy to facilitate the passage of stones: what is the evidence? Eur Urol 2009; 56: 455-471.